By inhibiting aromatase activity, letrozole induces an accumulation of androgens in the blood stream leading to hyperandrogenism [41] with the resulting blockage of the estrous cycle in the diestrus phase, since vaginal smears undergo cytological changes only according to the cyclical variations of serum estradiol levels [34]. This evidence concerns the gene CYP19A1 and hyperandrogenism.